Safety Assessment of TLPL/AY/03/2008, A Polyherbal Formulation in Sprague Dawley Rats



Acute, polyherbal, subchronic, toxicity, TLPL/AY/03/2008


Objectives: TLPL/AY/03/2008 is a polyherbal formulation intended for treatment of osteoarthritis, rheumatoid arthritis, lumbago, spondylitis etc., Acute and repeated dose 90"‘days studies were conducted to evaluate the safety profile of TLPL/AY/03/2008 in rats. Materials and Methods: In acute study, TLPL/AY/03/2008 was orally administered to Sprague Dawley rats at 2000 mg/kg. In repeated dose study, TLPL/AY/03/2008 was administered to rats at 200, 500 and 1000 mg/kg through oral gavage for 90 days and assessed for treatment related changes in body weight, feed consumption, hematological, biochemical and pathological parameters. Histopathological examination was conducted for tissues from control and the high dose groups and was extended to target organs from the lower dose and recovery groups. Results: In acute study, the test item did not produce any mortality or adverse clinical signs. In the 90"‘days oral toxicity study, animals did not exhibit any toxicity symptoms and no deaths were observed. No significant changes were found in hematological and biochemical endpoints. Also, toxicologically significant alterations in relative organ weights were not observed. Microscopic findings of mild to marked, diffuse hepatocellular degeneration (vacuolar changes with granular of cytoplasm and pyknotic nuclei of hepatocytes) was noticed in males at 1000 mg/kg body weight. Animals of recovery group (1000 mg/kg) did not show any changes when compared with control group animals indicating the complete reversal. Conclusions: Based on the findings of the study, the median lethal dose of TLPL/AY/03/2008 was found to be more than 2000 mg/kg. The No Observed Adverse Effect Level (NOAEL) of TLPL/AY/03/2008 can be considered as 1000 mg/kg in both male and female rats, under the experimental conditions and doses employed.


Download data is not yet available.


WHO Media Centre: Traditional Medicine. Fact sheet N°134 2008.Available from: fs134/en/] [Last accessed on 2012 June].

Ernst E. Frankincense: Systematic review. BMJ 2008;337:a2813.

Manjula N, Gayathri B, Vinaykumar KS, Shankernarayanan NP, Vishwakarma RA, Balakrishnan A. Inhibition of MAP kinases by crude extract and pure compound isolated from Commiphora mukul leads to down regulation of TNF"‘α, IL"‘1β and IL"‘2. Int Immunopharmacol 2006;6:122"‘32.

Veena S, Sadhana S, Pracheta, Ritu P. Withania somnifera: A rejuvenating ayurvedic medicinal herb for the treatment of various human ailments. Int J PharmTech Res 2011;3: 187"‘92.

Prakash O, Yamini T, Tripathi B. Antioxidant properties of different fractions of Vitex negundo Linn. Food Chem 2007;100:1170"‘6.

Raju I, Moni M. Subramanian V. Anti"‘inflammatory and free radical scavenging activity of Ricinus communis root extract.J Ethnopharmacol 2006;103:478"‘80.

Rani C, Chawla S, Mangal M, Mangal AK, Khagla S, Dhawan AK.Nyctanthes arbor"‘tristis Linn. (Night Jasmine): A sacred ornamental plant with immense medicinal potentials. Indian J Tradit Knowl 2012;11:427"‘35.

Singh G, Marimuthu P, Murali HS, Bawa AS. Antioxidative and antimicrobial potentials of essential oils and extracts isolated from various spice materials. J Food Safe 2005b; 25:130"‘45.

Singh G, Maurya SC, Catalan, Lampasona MP. Studies on essential oils, Part 42: Chemical, antifungal, antimicrobial and sprout suppressant studies on ginger essential oil and its oleoresin.Flav Frag J 2005c; 20:1"‘6.

Farzamfar B, Abdollahi M, Ka'abinejadian S, Heshmat R, Shahhosseiny MH, Novitsky A, et al. Sub"‘chronic toxicity study of a novel herbal"‘based formulation (Semelil) on dogs. Daru 2008;16:15"‘9.

Organisation for Economic Co"‘operation and Development (OECD). OECD guideline for testing of chemicals: Guideline 420, Acute oral toxicity"‘Fixed dose procedure, OECD, Paris, France, 2001.

Oreagba IA, Oshikoya KA, Amachree M. Herbal medicine use among urban residents in Lagos, Nigeria. BMC Complement Altern Med 2011;11:117.

Organisation for Economic Co"‘operation and Development(OECD). OECD guideline for testing of chemicals: Guideline 408, Repeated Dose 90"‘day Oral Toxicity Study in Rodents, OECD, Paris, France, 1998.

Homburger F. In vivo testing in the study of toxicity and safety evaluation. In: Marquis JK, editor. A Guide to General Toxicology, New York: Karger Continuing Education Series; 1989. p. 268"‘93.

Schilter B, Andersson C, Anton R, Constable A, Kleiner J, O'Brien J, et al. Guidance for the safety assessment of botanicals and botanical preparations for use in food and food supplements. Food Chem Toxicol 2003;41:1625"‘49.

Levine BS. Animal Clinical Pathology. In: Handbook of Toxicology, In: Derlanko MJ, Hollinger MA, editors. New York: CRC Press; 1995. p. 517"‘73.



How to Cite

Raghunatha Reddy, K. R., Vinaya Babu, S. N., Raghavendra, N., Sridhar, M., Nipanikar, S. U., & Kuber, V. V. (2018). Safety Assessment of TLPL/AY/03/2008, A Polyherbal Formulation in Sprague Dawley Rats. Toxicology International, 20(1), 77–86. Retrieved from



Original Research